Last $358.92 USD
Change Today -3.82 / -1.05%
Volume 2.6M
REGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

George D. Yancopoulos M.D., Ph.D.

Chief Scientific Officer, Executive Vice President, Director, Ex Officio Member of Technology Committee and President of Regeneron Research Laboratories, Regeneron Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 24 board members in 2 different organizations across 2 different industries.

See Board Relationships
54$31,017,593
As of Fiscal Year 2013

Background*

Dr. George D. Yancopoulos, M.D., Ph.D. has been Chief Scientific Officer and Executive Vice President of Regeneron Pharmaceuticals, Inc. since December 2000. Dr. Yancopoulos has been the President of Regeneron Research Laboratories, a subsidiary of Regeneron Pharmaceuticals, Inc. since December 2000. He served as the Senior Vice President, Research of Regeneron Research Laboratories, a position he held since June 1997, and Chief Scientific Officer, a position he held ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-347-7000
Fax: --

Board Members Memberships*

2001-Present
Chief Scientific Officer, Executive Vice President, Director, Ex Officio Member of Technology Committee and President of Regeneron Research Laboratories

Education*

PhD
Columbia University
MD
Columbia University

Other Affiliations*

Annual Compensation*

Salary$879,800
Bonus$1,759,500
Total Annual Compensation$2,639,300

Stock Options*

All Other Compensation$281,455
Exercised Options206,612
Exercised Options Value$48,865,143
Exercisable Options1,616,907
Exercisable Options Value$401,790,912
Unexercisable Options727,501
Unexercisable Options Value$95,752,096
Total Value of Options$546,408,151
Total Number of Options2,551,020

Total Compensation*

Total Annual Cash Compensation$2,920,755
Total Short Term Compensation$2,639,300
Other Long Term Compensation$281,455
Total Calculated Compensation$31,017,593
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REGN:US $358.92 USD -3.82

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
$1.4M
Leonard Bell M.D.Co-Founder, Chief Executive Officer, Treasurer and Director
Alexion Pharmaceuticals, Inc.
$1.2M
Frederic Roch Doliveux DVMChief Executive Officer and Executive Director
UCB SA
€2.1M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.